Finance

Results: 1729-1740 of 41576

PR Newswire associated0

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide

$300 Billion in Life Sciences Revenue at Risk. The Intelligence Behind It Is Months Old. Behavior Labs Launches a Decision Intelligence Platform That Addresses This Gap.

Capcom’s Monster Hunter Bridge to Reopen in Nijigen no Mori!

PR Newswire associated0

NYSE Content Update: Fourth Annual NYSE Sustainability Leaders Summit to Commence

Energy Vault Enters Japanese Market with Acquisition of 850 MW Energy Storage Portfolio, Set to Capture One of the World’s Fastest-Growing Energy Storage Markets

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

PR Newswire associated0

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

Lee Cronin, CEO and founder of Chemify, the deep-tech pioneer of Chemputation – a technological breakthrough that integrates AI- and ML-driven molecular discovery and automated, robotic synthesis – has published three peer-reviewed research papers in close succession, constituting a technological tour de force that validates Chemputation as a new paradigm for how small molecule-drugs and materials are discovered, designed and manufactured. The three publications in PNAS, Nature Communications Chemistry and Nature Communications Biology describe how the Chemputation AI platform can understand and execute instructions to make new molecules from scientific literature, produce them iteratively and how this could be applied to cancer research.

Chemify Founder Publishes Three Papers Validating Chemputation To Reimagine New Chemical Discovery and Development

INTRODUCING NATURE'S WELLNESS SANCTUARY AT 1 HOTEL HANALEI BAY

DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development

PR Newswire associated0

Miami International Holdings Announces the Passing of Board Member Murray Stahl

Moody’s Brings Credit and Compliance Workflows Directly into Anthropic’s Claude